BioHealth News
New Funding Secured to Support Clinical GMP Manufacturing Expansion at Rise Therapeutics
ROCKVILLE, Md., Oct. 23, 2024 /PRNewswire/ -- Rise Therapeutics announced today that it has received funding from the National Institute of Diabetes and Digestive and Kidney…
Read More
Biden-Harris Administration announces ARPA-H’s Sprint for Women’s Health awards aimed at closing gaps in women’s health research
The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS), today announced the teams…
Read More
Children’s National selected to receive $8 million award from ARPA-H’s Sprint for Women’s Health to advance device for precision pain measurement
WASHINGTON, D.C., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Pain assessment in medicine often relies on imprecise visual rating scales featuring smiling or crying faces,…
Read More
Frederick’s Theradaptive Receives 2024 Best Technology in Spine Award by Orthopedics This Week
FREDERICK, Md., Oct. 23, 2024 /PRNewswire/ -- Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair and targeted…
Read More
United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
SILVER SPRING, Md. & JACKSONVILLE, Fla.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, and its subsidiary Lung Bioengineering Inc. (LBE) announced that the…
Read More
TDR: BioHealth Capital Region Forum: A recap of innovation and collaboration
By: Tammi Thomas, Chief Development and Marketing Officer, TEDCO The 2024 BioHealth Capital Region Forum (BHCRF) once again solidified its position as the premier…
Read More
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
ROCKVILLE, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--Oct. 22, 2024-- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment…
Read More
USP Acquires Stratix Labs, Enhancing Its Microbiology Portfolio with Innovative Technology
ROCKVILLE, MD - October 21, 2024 – Today, the U.S. Pharmacopeia (USP) announced the acquisition of Stratix Labs, a microbiology technology company based in Saint Paul,…
Read More
BioBuzz: Advancing Pediatric Medical Countermeasures Through the Newly BARDA-Funded Accelerator, SPARK for Innovations in Pediatrics
This article originally appeared in the Association for the Advancement of Medical Instrumentation’s (AAMI) new Insights into Innovation series is authored by Kolaleh Eskandanian, Ph.D., M.B.A., P.M.P., vice president…
Read More
Revolutionizing Global Drug Manufacturing with Dr. Frank Gupton of Phlow and Medicines for All on BioTalk
[vc_row type="in_container" full_screen_row_position="middle" column_margin="default" column_direction="default" column_direction_tablet="default" column_direction_phone="default" scene_position="center" text_color="dark" text_align="left" row_border_radius="none" row_border_radius_applies="bg" overlay_strength="0.3" gradient_direction="left_to_right" shape_divider_position="bottom" bg_image_animation="none"][vc_column column_padding="no-extra-padding" column_padding_tablet="inherit" column_padding_phone="inherit" column_padding_position="all" column_element_spacing="default" background_color_opacity="1" background_hover_color_opacity="1" column_shadow="none"…
Read More
REGENXBIO Shares Positive Phase II Data on Wet AMD Treatment at AAO 2024
ROCKVILLE, Md., Oct. 21, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced positive data from the Phase II fellow eye sub-study evaluating the subretinal delivery of…
Read More
Technical.ly: New life sciences building is the latest step in Jane Shaab’s mission to make Baltimore embrace itself
This is How I Got Here, a series where we chart the career journeys of technologists. Want to tell your story? Get in touch. Baltimore’s reputation…
Read More
Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder
ROCKVILLE, Md., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the…
Read More
BIO Investor Forum opens with encouraging news on financing
The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in…
Read More
Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting
Company continues to expect to hold an End-of-Phase 2 meeting with the FDA by year-endGAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics,…
Read More